 | • レポートコード：QYR9N7502 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、悪性リンパ腫のグローバル市場について調査・分析したレポートで、種類別（ホジキンリンパ腫、非ホジキンリンパ腫）、用途別（製薬会社、病院、学術研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・悪性リンパ腫の世界市場規模 ・主要企業別市場シェア ・悪性リンパ腫の世界市場規模：種類別（ホジキンリンパ腫、非ホジキンリンパ腫） ・悪性リンパ腫の世界市場規模：用途別（製薬会社、病院、学術研究機関） ・悪性リンパ腫のアメリカ市場規模（種類別、用途別） ・悪性リンパ腫のヨーロッパ市場規模（種類別、用途別） ・悪性リンパ腫の中国市場規模（種類別、用途別） ・悪性リンパ腫の日本市場規模（種類別、用途別） ・悪性リンパ腫の東南アジア市場規模（種類別、用途別） ・悪性リンパ腫のインド市場規模（種類別、用途別） ・悪性リンパ腫の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・悪性リンパ腫の世界市場予測（2019年-2025年） ・悪性リンパ腫の地域別市場予測（2019年-2025年） ... |
Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part of the immune system. The immune system’s job is to produce blood cells and protect against harm from invading germs.The two main types of malignant lymphoma are Hodgkin lymphoma(also known as Hodgkin disease) and NHL. The two types spread in different ways and respond differently to treatment. When lymphomais of a slow-growing variety, it is referred to as low-grade. Aggressive, fast-growing types are called high-grade. A biopsy can also detect the difference between Hodgkin lymphomaand NHL, as well as their various sub-types. Along with imaging and blood tests, the biopsy results will help doctor determine course of treatment.
In 2018, the global Malignant Lymphoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Malignant Lymphoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Lymphoma development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Abiogen Pharma
Actelion Pharmaceuticals
Bristol-Myers Squibb
…
Market segment by Type, the product can be split into
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Market segment by Application, split into
Pharmaceutical Companies
Hospitals
Academic And Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Malignant Lymphoma status, future forecast, growth opportunity, key market and key players.
To present the Malignant Lymphoma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Malignant Lymphoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Malignant Lymphoma Market Size Growth Rate by Type (2014-2025)
1.4.2 Hodgkin Lymphoma
1.4.3 Non-Hodgkin Lymphoma
1.5 Market by Application
1.5.1 Global Malignant Lymphoma Market Share by Application (2014-2025)
1.5.2 Pharmaceutical Companies
1.5.3 Hospitals
1.5.4 Academic And Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Malignant Lymphoma Market Size
2.2 Malignant Lymphoma Growth Trends by Regions
2.2.1 Malignant Lymphoma Market Size by Regions (2014-2025)
2.2.2 Malignant Lymphoma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Malignant Lymphoma Market Size by Manufacturers
3.1.1 Global Malignant Lymphoma Revenue by Manufacturers (2014-2019)
3.1.2 Global Malignant Lymphoma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Malignant Lymphoma Market Concentration Ratio (CR5 and HHI)
3.2 Malignant Lymphoma Key Players Head office and Area Served
3.3 Key Players Malignant Lymphoma Product/Solution/Service
3.4 Date of Enter into Malignant Lymphoma Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Malignant Lymphoma Market Size by Type (2014-2019)
4.2 Global Malignant Lymphoma Market Size by Application (2014-2019)
5 United States
5.1 United States Malignant Lymphoma Market Size (2014-2019)
5.2 Malignant Lymphoma Key Players in United States
5.3 United States Malignant Lymphoma Market Size by Type
5.4 United States Malignant Lymphoma Market Size by Application
6 Europe
6.1 Europe Malignant Lymphoma Market Size (2014-2019)
6.2 Malignant Lymphoma Key Players in Europe
6.3 Europe Malignant Lymphoma Market Size by Type
6.4 Europe Malignant Lymphoma Market Size by Application
7 China
7.1 China Malignant Lymphoma Market Size (2014-2019)
7.2 Malignant Lymphoma Key Players in China
7.3 China Malignant Lymphoma Market Size by Type
7.4 China Malignant Lymphoma Market Size by Application
8 Japan
8.1 Japan Malignant Lymphoma Market Size (2014-2019)
8.2 Malignant Lymphoma Key Players in Japan
8.3 Japan Malignant Lymphoma Market Size by Type
8.4 Japan Malignant Lymphoma Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Malignant Lymphoma Market Size (2014-2019)
9.2 Malignant Lymphoma Key Players in Southeast Asia
9.3 Southeast Asia Malignant Lymphoma Market Size by Type
9.4 Southeast Asia Malignant Lymphoma Market Size by Application
10 India
10.1 India Malignant Lymphoma Market Size (2014-2019)
10.2 Malignant Lymphoma Key Players in India
10.3 India Malignant Lymphoma Market Size by Type
10.4 India Malignant Lymphoma Market Size by Application
11 Central & South America
11.1 Central & South America Malignant Lymphoma Market Size (2014-2019)
11.2 Malignant Lymphoma Key Players in Central & South America
11.3 Central & South America Malignant Lymphoma Market Size by Type
11.4 Central & South America Malignant Lymphoma Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Malignant Lymphoma Introduction
12.1.4 Abbott Laboratories Revenue in Malignant Lymphoma Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Abiogen Pharma
12.2.1 Abiogen Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Malignant Lymphoma Introduction
12.2.4 Abiogen Pharma Revenue in Malignant Lymphoma Business (2014-2019)
12.2.5 Abiogen Pharma Recent Development
12.3 Actelion Pharmaceuticals
12.3.1 Actelion Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Malignant Lymphoma Introduction
12.3.4 Actelion Pharmaceuticals Revenue in Malignant Lymphoma Business (2014-2019)
12.3.5 Actelion Pharmaceuticals Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Malignant Lymphoma Introduction
12.4.4 Bristol-Myers Squibb Revenue in Malignant Lymphoma Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Malignant Lymphoma Key Market Segments
Table Key Players Malignant Lymphoma Covered
Table Global Malignant Lymphoma Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Malignant Lymphoma Market Size Market Share by Type 2014-2025
Figure Hodgkin Lymphoma Figures
Table Key Players of Hodgkin Lymphoma
Figure Non-Hodgkin Lymphoma Figures
Table Key Players of Non-Hodgkin Lymphoma
Table Global Malignant Lymphoma Market Size Growth by Application 2014-2025 (Million US$)
Figure Pharmaceutical Companies Case Studies
Figure Hospitals Case Studies
Figure Academic And Research Institutes Case Studies
Figure Malignant Lymphoma Report Years Considered
Table Global Malignant Lymphoma Market Size 2014-2025 (Million US$)
Figure Global Malignant Lymphoma Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Malignant Lymphoma Market Size by Regions 2014-2025 (Million US$)
Table Global Malignant Lymphoma Market Size by Regions 2014-2019 (Million US$)
Table Global Malignant Lymphoma Market Share by Regions 2014-2019
Figure Global Malignant Lymphoma Market Share by Regions 2014-2019
Figure Global Malignant Lymphoma Market Share by Regions 2019
Table Market Top Trends
Table Global Malignant Lymphoma Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Malignant Lymphoma Market Share by Manufacturers (2014-2019)
Figure Global Malignant Lymphoma Market Share by Manufacturers in 2018
Table Global Malignant Lymphoma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Malignant Lymphoma Product/Solution/Service
Table Date of Enter into Malignant Lymphoma Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table Global Malignant Lymphoma Market Size Share by Type (2014-2019)
Figure Global Malignant Lymphoma Market Size Market Share by Type (2014-2019)
Table Global Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table Global Malignant Lymphoma Market Size Share by Application (2014-2019)
Figure Global Malignant Lymphoma Market Size Market Share by Application (2014-2019)
Figure Global Malignant Lymphoma Revenue Market Share by Application in 2018
Figure United States Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table United States Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table United States Key Players Malignant Lymphoma Market Share (2018-2019)
Table United States Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table United States Malignant Lymphoma Market Share by Type (2014-2019)
Table United States Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table United States Malignant Lymphoma Market Share by Application (2014-2019)
Figure Europe Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table Europe Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table Europe Key Players Malignant Lymphoma Market Share (2018-2019)
Table Europe Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table Europe Malignant Lymphoma Market Share by Type (2014-2019)
Table Europe Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table Europe Malignant Lymphoma Market Share by Application (2014-2019)
Figure China Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table China Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table China Key Players Malignant Lymphoma Market Share (2018-2019)
Table China Malignant Lymphoma Market Size by Type (2014-20189) (Million US$)
Table China Malignant Lymphoma Market Share by Type (2014-2019)
Table China Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table China Malignant Lymphoma Market Share by Application (2014-2019)
Figure Japan Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table Japan Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table Japan Key Players Malignant Lymphoma Market Share (2018-2019)
Table Japan Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table Japan Malignant Lymphoma Market Share by Type (2014-2019)
Table Japan Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table Japan Malignant Lymphoma Market Share by Application (2014-2019)
Figure Southeast Asia Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Malignant Lymphoma Market Share (2018-2019)
Table Southeast Asia Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Malignant Lymphoma Market Share by Type (2014-2019)
Table Southeast Asia Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Malignant Lymphoma Market Share by Application (2014-2019)
Figure India Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table India Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table India Key Players Malignant Lymphoma Market Share (2018-2019)
Table India Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table India Malignant Lymphoma Market Share by Type (2014-2019)
Table India Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table India Malignant Lymphoma Market Share by Application (2014-2019)
Figure Central & South America Malignant Lymphoma Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Malignant Lymphoma Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Malignant Lymphoma Market Share (2018-2019)
Table Central & South America Malignant Lymphoma Market Size by Type (2014-2019) (Million US$)
Table Central & South America Malignant Lymphoma Market Share by Type (2014-2019)
Table Central & South America Malignant Lymphoma Market Size by Application (2014-2019) (Million US$)
Table Central & South America Malignant Lymphoma Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Malignant Lymphoma Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Malignant Lymphoma Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Abiogen Pharma Company Details
Table Abiogen Pharma Revenue in Malignant Lymphoma Business (2014-2019)(Million US$)
Figure Abiogen Pharma Revenue Growth Rate in Malignant Lymphoma Business (2014-2019)
Table Abiogen Pharma Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Revenue in Malignant Lymphoma Business (2014-2019)(Million US$)
Figure Actelion Pharmaceuticals Revenue Growth Rate in Malignant Lymphoma Business (2014-2019)
Table Actelion Pharmaceuticals Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Malignant Lymphoma Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Malignant Lymphoma Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Malignant Lymphoma Market Size by Regions (Million US$) 2019-2025
Figure Global Malignant Lymphoma Market Size Share by Regions (2019-2025)
Figure Global Malignant Lymphoma Market Size Share by Regions in 2025
Figure United States Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Figure Europe Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Figure China Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Figure Japan Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Figure India Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Malignant Lymphoma Market Size Forecast (2019-2025)(Million USD)
Table Global Malignant Lymphoma Market Size by Product (2019-2025) (Million US$)
Figure Global Malignant Lymphoma Market Size by Product (2019-2025)
Figure Global Malignant Lymphoma Market Size by Product in 2025
Table Global Malignant Lymphoma Market Size by Application (2019-2025) (Million US$)
Figure Global Malignant Lymphoma Market Size by Application (2019-2025)
Figure Global Malignant Lymphoma Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の濾胞性リンパ腫市場：市場規模・現状・予測 Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…- 世界の悪性神経膠腫市場：市場規模・現状・予測 Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and pr…
- 世界の悪性神経膠腫薬市場：市場規模・現状・予測 Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and pr…
- 世界の悪性黒色腫薬市場：市場規模・現状・予測 In 2018, the global Malignant Melanoma Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Malignant Melanoma Drugs status, future forecast, growth opportunity, key market and key players. Th…
- 世界の悪性中皮腫市場：市場規模・現状・予測 Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium).Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the forecas…